Anti-N-methyl-D-aspartate receptor encephalitis: A targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management
February 28, 2014
Anti-N-methyl-D-aspartate receptor encephalitis: A targeted review of clinical presentation, diagnosis, and approaches to psychopharmacologic management
Kruse et al
Annals of Clinical Psychiatry. 2014 Feb;26(1):e1-9
https://www.researchgate.net/profile/Michael_Davis27/publication/260118368_Anti-N-methyl-D-aspartate_receptor_encephalitis_A_targeted_review_of_clinical_presentation_diagnosis_and_approaches_to_psychopharmacologic_management/links/559b423708ae5d8f39380611/Anti-N-methyl-D-aspartate-receptor-encephalitis-A-targeted-review-of-clinical-presentation-diagnosis-and-approaches-to-psychopharmacologic-management.pdf
Anti-N-methyl-d-aspartate receptor encephalitis was formally described in 2007 and includes a range of psychiatric and neurologic symptoms. Most patients with anti-NMDAR encephalitis initially present to psychiatrists for diagnosis and treatment. However, there is limited literature summarizing treatment strategies for psychiatric symptoms. In an effort to improve identification and treatment, this review article provides an overview of anti-NMDAR encephalitis, with a focus on psycho- pharmacologic treatment strategies.
– Abstract from researchgate.net
